Behind the markets
Behind the markets

Daily Trades

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: 3 Companies at the Forefront of the Weight-Loss Revolution.” (LLY, NVO, VKTX)

The Wall Street Journal calls this new drug “King Kong”…
Learn More

September 2023 Issue: Recursion Pharmaceuticals (SYM: RXRX)

The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Learn More

TRADE ALERT: Eli Lilly up $50 on weight-loss drug

Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: 3 Companies at the Forefront of the Weight-Loss Revolution.”

This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
Learn More

SPECIAL REPORT May 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Specifically, this month I’m recommending 3 stocks that are on the verge of BOOMING with new weight loss drugs hitting the market.
Learn More

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: 3 Companies at the Forefront of the Weight-Loss Revolution.” (LLY, NVO, VKTX)

The Wall Street Journal calls this new drug “King Kong”…
Learn More

September 2023 Issue: Recursion Pharmaceuticals (SYM: RXRX)

The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Learn More

TRADE ALERT: Eli Lilly up $50 on weight-loss drug

Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: 3 Companies at the Forefront of the Weight-Loss Revolution.”

This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
Learn More

SPECIAL REPORT May 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Specifically, this month I’m recommending 3 stocks that are on the verge of BOOMING with new weight loss drugs hitting the market.
Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

585 subscribers

Behind the Markets: independent research for independent investors.

Behind the Markets
🌟 Today's update is nothing short of groundbreaking – our core holding, ImmunoGen, just got acquired by AbbVie at a staggering $31.26 per share! 🚀 This marks our second major takeover in the cancer oncology sub-sector in the past year, with CGEN being scooped up by Pfizer for a whopping $43 billion back in March. These wins are great and all but there's more to it than that. My goal is to provide you with the why and the happenings behind the scenes. 💡 Now, let's dive into why these takeovers are happening, and it all boils down to one word: ADCs, or antibody drug conjugates. These are often referred to as "smart chemo." Imagine a new class of drugs delivering toxic agents directly to tumor cells while sparing normal cells – that's the game-changing magic of ADCs. 🩹 For those who've faced the harsh reality of cancer, you'll understand the importance of minimizing damage to healthy cells during treatment. Traditional chemotherapy, or "chemical therapy," can be compared to dropping nuclear bombs on your immune system – indiscriminate and damaging. ADCs, on the other hand, act like precision smart bombs, targeting only the tumors and bad cells, a true revolution in precision medicine. 🌐 This breakthrough has the potential to change the narrative around cancer treatment. Our mission at Behind the Markets is to stay ahead of the curve in the oncology sphere, and we're currently delving into a myriad of other ADC companies in late phase two and early phase three trials. 🕵️‍♂️ We're on the lookout for the next big takeover targets in the biotech sector, and I promise to keep you in the loop every step of the way. 🚀 Join us on this exciting journey of innovation and life-changing advancements. Hit that subscribe button, like this video, and let's continue to decode the future of biotech together. Thank you for being part of the Behind the Markets community! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkFzQnNSYmhvbF9J

The Reason ImmunoGen Was Taken Over Today

🎉 Hey everyone, it's Dylan Jovine, and I am back with a video that's a bit different from my usual content. This week, I want to pay tribute to one of my business mentors, the legendary Charlie Munger, who unfortunately passed away recently. In this video, I'm going to share three quotes from Charlie that have had a profound impact on my life and business journey. Each of these quotes holds valuable lessons that I believe we can all learn from. They have been a compass in the business world for the past two or three decades, and I'm excited to share them with you. Join me as I delve into each quote, sharing personal anecdotes and insights that have shaped my perspective on business and life. 👍 If you find these quotes as impactful as I have, don't forget to hit the like button, subscribe, and share your thoughts in the comments below. Let's continue to learn and grow together. Thanks for being part of this community! 🚀 ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LnJJeGNUNkZGdnVv

3 Things I Learned from Charlie Munger

✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LjRIMFJjeWxSQ3Rj

Dylan Jovine - "Uncovering the Game-Changing Drug of the Decade"

Load More... Subscribe

Recent posts

3 Stocks in Takeover Talks – Week of 12/03

3 “Strong Buy” Stocks from Wall Street – Week of 12/03

3 of Warren Buffett’s Favorite Stocks – Week of 11/26

5 insiders buy $2.8 mil of Small-Cap – Week of 11/26

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2023 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.